| Price | 0.16p on 12-08-2026 at 15:15:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.17p |
| Sell | 0.15p |
| Last Trade: | Sell 969,208.00 at 0.1525p |
| Day's Volume: | 3,690,412 |
| Last Close: | 0.16p |
| Open: | 0.16p |
| ISIN: | GB00BLH13C52 |
| Day's Range | 0.16p - 0.16p |
| 52wk Range: | 0.135p - 0.78p |
| Market Capitalisation: | £2.11m |
| VWAP: | 0.156733p |
| Shares in Issue: | 1.32b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
ValiRx (VAL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 969,208 | 0.1525p | Ordinary |
14:07:00 - 12-Aug-26 |
| Sell* | 1,209,702 | 0.1525p | Ordinary |
11:00:06 - 12-Aug-26 |
| Sell* | 111,500 | 0.15p | Ordinary |
10:30:01 - 12-Aug-26 |
| Buy* | 1,000,000 | 0.1638p | Ordinary |
10:13:45 - 12-Aug-26 |
| Sell* | 1 | 0.1525p | Ordinary |
08:20:09 - 12-Aug-26 |
| Sell* | 1 | 0.1525p | Ordinary |
08:20:05 - 12-Aug-26 |
| Buy* | 400,000 | 0.164p | Ordinary |
08:08:04 - 12-Aug-26 |
| Buy* | 882 | 0.17p | Ordinary |
16:01:56 - 11-Aug-26 |
| Buy* | 269,515 | 0.164p | Ordinary |
14:38:48 - 11-Aug-26 |
| Buy* | 89,030 | 0.164p | Ordinary |
13:42:01 - 11-Aug-26 |
ValiRx (VAL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 7:00 am | RNS | Cytolytix Patent Update |
| 17th Jul 2026 12:25 pm | RNS | Result of AGM, Warrants & Directorate Change |
| 22nd Jun 2026 7:00 am | RNS | Conclusion of Evaluation with University of Dundee |
| 22nd Jun 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 2nd Jun 2026 7:00 am | RNS | Conclusion of Evaluation with Stingray |
| 1st Jun 2026 7:00 am | RNS | ValiRx Exercises Option on Evaluation Asset |
| 27th May 2026 7:00 am | RNS | Cytolytix Patent Granted |
| 21st May 2026 7:00 am | RNS | Result of Oversubscribed WRAP Retail Offer |
| 18th May 2026 7:00 am | RNS | WRAP Retail Offer for up to £150,000 |
| 15th May 2026 7:00 am | RNS | Fundraising of up to £1,155,000 |
